The administration of S. salivarius K12 to children may reduce the rate of SARS-CoV-2 infection. | Minerva Med;112(4): 514-516, 2021 08. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

WHO COVID-19 Research Database

News/Update/Help

Advanced Search

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

The administration of S. salivarius K12 to children may reduce the rate of SARS-CoV-2 infection.

DI Pierro, Francesco; Colombo, Maria.

DI Pierro F; Velleja Research, Milan, Italy - f.dipierro@vellejaresearch.com.
Colombo M; Digestive Endoscopic Unit and Gastroenterology, Fondazione Poliambulanza, Brescia, Italy - f.dipierro@vellejaresearch.com.

Minerva Med ; 112(4): 514-516, 2021 08.

Article in English | MEDLINE | ID: covidwho-1134672

Subject(s)

COVID-19/prevention & control; Probiotics/therapeutic use; Streptococcus salivarius; Child; Humans

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Probiotics / Streptococcus salivarius / COVID-19 Limits: Child / Humans Language: English Journal: Minerva Med Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Probiotics / Streptococcus salivarius / COVID-19 Limits: Child / Humans Language: English Journal: Minerva Med Year: 2021 Document Type: Article